# Caution: de-escalating radiation on HPV status alone

Source: https://onco.cc/pairings/hpv-deescalation-caution/  
OnCo record `hpv-deescalation-caution` (Pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Being HPV-positive is not enough to justify less radiation; trials that tried it saw more relapses.

## Summary

This caution warns against reducing radiotherapy for HPV-positive, p16-positive head and neck cancer on the basis of HPV status alone. HPV-positive tumours are heterogeneous in smoking exposure, nodal burden and biology, so a single marker over-selects patients for less treatment. Multiple randomised trials bear this out: the 60 Gy arms of NRG-HN005, and the cetuximab-substitution trials RTOG 1016 and De-ESCALaTE, all underperformed standard cisplatin chemoradiation with modern external beam radiotherapy, with more relapses. The current approach is response-adapted selection, or selection guided by circulating tumour HPV DNA, rather than HPV status at diagnosis.

## Fields

- Kind: Pairing
- Last checked: 2026-09-07
- Pairs: HPV-positive (p16) head and neck cancer + IMRT / IGRT (modern external beam)
- Type: caution
- Rationale: HPV-positive tumours are heterogeneous in smoking exposure, nodal burden, and biology; a single marker over-selects.
- Evidence: Multiple randomised trials.

## Sources

- ClinicalTrials.gov NCT03952585: NRG-HN002 & NRG-HN005 (HPV+ de-escalation): https://clinicaltrials.gov/study/NCT03952585

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [HPV-positive oropharyngeal cancer](https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/)
- technologies: [Circulating tumour HPV DNA (ctHPV-DNA)](https://onco.cc/technologies/cthpv-dna/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- terms: [HPV-positive (p16) head and neck cancer](https://onco.cc/terms/hpv-p16/)
- trials: [NRG-HN002 & NRG-HN005 (HPV+ de-escalation)](https://onco.cc/trials/nrg-hn002-hn005/)

---
JSON: https://onco.cc/api/v1/entities/hpv-deescalation-caution.json